Skip to Content

IG 271 1.25mg (Ramipril 1.25 mg)

Pill with imprint IG 271 1.25mg is Yellow, Capsule-shape and has been identified as Ramipril 1.25 mg. It is supplied by InvaGen Pharmaceuticals, Inc..

Ramipril is used in the treatment of high blood pressure; left ventricular dysfunction; heart failure; diabetic kidney disease; cardiovascular risk reduction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IG 271 1.25mg

Ramipril 1.25 mg IG 271 1.25mg
Ramipril 1.25 mg IG 271 1.25mg
Ramipril 1.25 mg IG 271 1.25mg

Ramipril

Imprint
IG 271 1.25mg
Strength
1.25 mg
Color
Yellow
Size
4.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC)
67787-0271

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.